Published in Arzneimittelforschung on January 01, 1988
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. Br J Clin Pharmacol (1998) 3.17
Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations. Cardiovasc Drugs Ther (1993) 0.78
Clinical pharmacology of loop diuretics. Drugs (1991) 0.78
A simplified HPLC method for quantification of torsemide from human plasma and its application to a bioequivalence study. Indian J Pharm Sci (2010) 0.75
The loop diuretic torasemide in chronic renal failure. Pharmacokinetics and pharmacodynamics. Drugs (1991) 0.75
Acute and long term effects of loop diuretics in heart failure. Drugs (1991) 0.75
The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide. Drugs (1991) 0.75
Torasemide in the treatment of patients with cirrhosis and ascites. Cardiovasc Drugs Ther (1993) 0.75
Pharmacokinetics and pharmacodynamics of torasemide in patients with chronic renal insufficiency--preliminary evaluation. Cardiovasc Drugs Ther (1993) 0.75
Pharmacokinetics and disposition of carvedilol in humans. J Cardiovasc Pharmacol (1987) 1.22
Absolute bioavailability and bioequivalence of glibenclamide (Semi-Euglucon N). Int J Clin Pharmacol Ther Toxicol (1985) 0.88
Solid-phase extraction and liquid chromatography of torsemide and metabolites from plasma and urine. J Pharm Sci (1990) 0.85
Clinical and pharmacological investigations of the new saluretic azosemid. Eur J Clin Pharmacol (1978) 0.83
Pharmacokinetic and hemostatic properties of the recombinant plasminogen activator bm 06.022 in healthy volunteers. Thromb Haemost (1991) 0.82
High-performance liquid chromatography of naftopidil, a novel antihypertensive drug, and two metabolites in human plasma. J Chromatogr (1990) 0.80
Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver. Arzneimittelforschung (1988) 0.80
[Steady state kinetics of isosorbide-5-mononitrate in patients with coronary disease]. Med Welt (1981) 0.78
Clinical pharmacologic investigations with carvedilol, a new beta-blocker with direct vasodilator activity. Clin Pharmacol Ther (1986) 0.78
[Investigation of the viability of radioactively labelled bacteria after adsorption on activated charcoal (author's transl)]. Zentralbl Bakteriol Mikrobiol Hyg A (1981) 0.78
Measurement of carcinoembryonic antigen. Clin Chem (1973) 0.78
Haemodynamic abnormalities in hypertensive patients: a review of the influence of vasodilating drugs. J Int Med Res (1986) 0.77
Dose-ranging study of the novel recombinant plasminogen activator BM 06.022 in healthy volunteers. Clin Pharmacol Ther (1991) 0.75
BM 12.434, a novel compound with vasodilating and beta-adrenoceptor-blocking activities. Clin Sci (Lond) (1981) 0.75
[Occupational medicine aspects of quinine production]. Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie (1983) 0.75
[Comparative studies uith a new protein test strip]. Med Lab (Stuttg) (1978) 0.75
Study of potential kinetic interactions of picumast dihydrochloride and theophylline in vitro and after oral administration in man. Arzneimittelforschung (1989) 0.75
Comparison of carcinoembryonic antigen (CEA) methodologies. Ann Clin Lab Sci (1974) 0.75
[The effect of orthostasis on the fructosamine value]. Wien Klin Wochenschr Suppl (1990) 0.75
Pharmacokinetics of picumast after administration of 14C-picumast dihydrochloride in dogs, rats, rabbits and monkeys. Arzneimittelforschung (1989) 0.75
On the bound state of alkali cations in subcellular preparations of rat liver. Hoppe Seylers Z Physiol Chem (1975) 0.75
Digital pulse plethysmography--a tool for investigating vasoactive substances. Methods Find Exp Clin Pharmacol (1985) 0.75
Pharmacokinetics of picumast dihydrochloride in patients with liver cirrhosis. Arzneimittelforschung (1989) 0.75
Pharmacokinetics of picumast dihydrochloride and its active metabolites M1 and M2 in humans. Arzneimittelforschung (1989) 0.75
Pharmacokinetics of the thioether phospholipid analogue BM 41.440 in rats. Lipids (1987) 0.75
Quinidine-digoxin interaction: evidence for involvement of an extrarenal mechanism. Eur J Clin Pharmacol (1982) 0.75
Enzymatic inhibition assay for fluorometric determination of allopurinol and oxipurinol in serum and urine. Arzneimittelforschung (1980) 0.75